Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Phase: PHASE3 | Sponsor: University of Virginia | Compound: Ketamine

Status

planned

Institution

University of Virginia

Start date

2025-08-01

End date

2029-12-01

Registry ID

NCT06907173

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.